Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by pmartino
Group name EquipePM
Item Type Journal Article
Title Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept
Creator Sgarbura et al.
Author Olivia Sgarbura
Author Mohammed Al Hosni
Author Andrea Petruzziello
Author Rodrigo Figueroa
Author Lakhdar Khellaf
Author Marie-Hélène Pissas
Author Sébastien Carrère
Author Stephanie Nougaret
Author Frédéric Bibeau
Author François Quénet
Abstract Introduction: Pseudomyxoma peritonei (PMP) is a rare disease characterized by the progressive accumulation of mucinous ascites and peritoneal implants. The optimal treatment for PMP includes the association of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). For patients with a large burdensome disease, the completeness of cytoreduction sometimes requires maximal effort surgery. The aim of this article is to provide proof of concept for two stage cytoreductive surgery (CRS) in this category of patients.Methods and materials: A two stage CRS and HIPEC with oxaliplatin was proposed for patients with bulky PMP including important involvement of the serosal surfaces of the bowel or colon who had an impaired nutritional status. The residual disease at the end of the first stage was less than 5?mm of thickness on several implants. Clinical, surgical and histopathological variables were analyzed.Results: All eight patients completed the two-stage strategy. Mortality was nil. One Clavien Dindo grade 3 event occurred in each stage. After a median follow up of 29.5?months, all patients were alive and free of recurrence. All of the patients had histopathological complete response on the specimens obtained from the residual sites during the second stage surgery.Conclusions: Two-stage surgical strategy is feasible for bulky PMP patients and it is associated with little high-grade morbidity and enhanced visceral sparing.
Publication International Journal of Hyperthermia: The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Volume 37
Issue 1
Pages 585-591
Date 2020
Journal Abbr Int J Hyperthermia
Language eng
DOI 10.1080/02656736.2020.1772511
ISSN 1464-5157
Short Title Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei
Library Catalog PubMed
Extra 00000 PMID: 32484014
Tags clinic, hyperthermic intraperitoneal chemotherapy, last, oxaliplatin, Pseudomyxoma peritonei, two-stage surgery
Date Added 2020/06/05 - 11:51:04
Date Modified 2020/06/05 - 11:54:14
Notes and Attachments Full Text (Attachment)
PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés